Ultrahuman, which seeks to improve diet and exercise based on glucose biomarkers, raised $17.5 million in Series B funding. Alpha Wave Incubation, which is managed by Falcon Edge Capital, invested in the round, alongside Steadview Capital, Nexus Venture Partners, Blume Ventures and Utsav Somani's iSeed fund.

Opya Inc., a San Mateo, Calif.-based provider of early intervention therapy for children with autism, snagged a $15.4 million Series A round. New investors including Panoramic Ventures, SB Opportunity Fund, Disability Opportunity Fund and Raven One Ventures were joined by previous backers Divergent Investments and Altitude Ventures in the funding. Austin Poole of Panoramic Ventures will join the board.

Element5, a San Jose, Calif.-based startup whose technology simplifies work for post-acute care organizations, fetched $15 million in Series A financing. Insight Partners led the round, with Jared Rosen joining the board.

Circles, a San Francisco-based emotional support platform, was seeded with an $8 million investment led by NFX and Flint Capital.

More Health News

Sleep apnea sufferers scramble after Philips recall of critical machine

Covid-19 booster shot to be offered to Americans fully vaccinated with Pfizer, Moderna

Biden tells nursing homes to vaccinate staffs to keep Medicare, Medicaid funds

Around the Web

Verily scoops up a fellow software maker as Amy Abernethy scales its clinical trials platform (Endpoints News)

Racial inequities persist in healthcare despite expanded insurance (New York Times)

(END) Dow Jones Newswires

08-19-21 0953ET